The effect of circadian rhythms modulation for gait initiation in people with Parkinson’s disease

Not Applicable

Recruiting

• Conditions: Parkinson disease.; Parkinson's disease

• Registration Number: IRCT20221014056170N1
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 16

Inclusion Criteria

Age between 40 and 75 years.
Idiopathic Parkinson's disease diagnosed by a neurologist.
Being in stages 2 and 3 of the disease based on the Hoehn and Yahr scale.
The ability to walk independently without the need for mobility aids (such as canes and walkers) for 30 minutes.

Exclusion Criteria

Presence of accompanying neurological disorders or history of other neurological disorders or major psychiatric illness.
The presence of cognitive disorders affecting the study.
Drug and alcohol addiction.
The presence of vision and hearing problems, which affect the patient's ability to perform the test correctly.
The presence of sensory problems in the legs or musculoskeletal disorders in the lower limbs.
Suffering from chronic back pain and the presence of a prosthesis in the lower limb that limits the range of movements.
Having severe tremors, a score greater than 2 on any of the items 3.15a to 3.17e on the clinical test (MDS-UPDRS).
History of episodes of freezing of gait or dyskinesia
History of implant surgery (Deep brain stimulation or DBS)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Circadian rhythms function. Timepoint: Measurements will be taken before using the glasses and 14 days after using the glasses. Method of measurement: Examining the daily sleep pattern.;Anticipatory postural adjustment. Timepoint: Measurements will be taken before using the glasses and 14 days after using the glasses. Method of measurement: Gait analysis and Electromyography indicators.;Gait initiation. Timepoint: Measurements will be taken before using the glasses and 14 days after using the glasses. Method of measurement: Gait analysis and Electromyography indicators.;Severity of Parkinson's disease. Timepoint: Measurements will be taken before using the glasses and 14 days after using the glasses. Method of measurement: Unified Parkinson’s Disease Rating Scale or UPDRS.